Global pharmaceutical giants make billions of dollars in Australia but pay a fraction of that in tax. They say the price they ...

The explosion in the use of costly GLP-1 drugs has helped fuel a 9.3% jump in per-person drug costs for CT residents.

It isn’t uncommon for insurance premiums to rise annually, but the statewide average of 28% is notably higher than the increase in years past: 5.6% in 2025, 9.7% in 2024, 10.4% in 2023 and 1.1% in ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare ...

Discover Fulton County's latest budget updates, health initiatives, and a proposed public health levy to secure vital services into the future.

New permanent tax exclusions and expanded funds usage give benefit leaders the opportunity to bolster their financial ...

The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide ...

The largest healthcare stocks by market capitalization are undergoing significant sell-offs. UnitedHealth is still a large ...

Dr Bryan Betty joined Jack Tame to discuss Wegovy – what it is, how you use it, the side effects, and why people are seeking medical treatment for their weight. A once-weekly injection for weight loss ...

The preventative healthcare measures recommended in the Scotland’s Population Health Framework 2025-2035 plan have been ...

The following is a special feature from CivicScience CEO and Founder John Dick. Learn how you can turn insights like these ...